Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries

Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Schizophrenia research 2012-07, Vol.138 (2), p.192-197
Hauptverfasser: Salokangas, Raimo K.R, Ruhrmann, Stephan, von Reventlow, Heinrich Graf, Heinimaa, Markus, Svirskis, Tanja, From, Tiina, Luutonen, Sinikka, Juckel, Georg, Linszen, Don, Dingemans, Peter, Birchwood, Max, Patterson, Paul, Schultze-Lutter, Frauke, Klosterkötter, Joachim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 197
container_issue 2
container_start_page 192
container_title Schizophrenia research
container_volume 138
creator Salokangas, Raimo K.R
Ruhrmann, Stephan
von Reventlow, Heinrich Graf
Heinimaa, Markus
Svirskis, Tanja
From, Tiina
Luutonen, Sinikka
Juckel, Georg
Linszen, Don
Dingemans, Peter
Birchwood, Max
Patterson, Paul
Schultze-Lutter, Frauke
Klosterkötter, Joachim
description Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim was to examine distributions of life-time and current Axis I diagnoses, and their association with TTP in CHR patients. Methods In the EPOS (European Prediction of Psychosis Study) project, six European outpatient centres in four countries examined 245 young help-seeking patients, who fulfilled the inclusion criteria for clinical risk of psychosis according to the Structured Interview for Prodromal Syndromes (SIPS 3.0) or the Bonn Scale for the Assessment of Basic Symptoms — Prediction List basic symptoms (BASBS-P). Patients who had experienced a psychotic episode lasting more than one week were excluded. Baseline and life-time diagnoses were assessed by the Structured Clinical Interview for DSM-IV (SCID-I). TTP was defined by continuation of BLIPS for more than seven days and predicted in Cox-regression analysis. Results Altogether, 71% of the CHR patients had one or more life-time and 62% one or more current SCID-I diagnosis; about a half in each category received a diagnosis of life-time depressive and anxiety disorder. Currently, 34% suffered from depressive and 39% from anxiety disorder. Four percent received a current SCID diagnosis of bipolar, and 6.5% of somatoform disorder. During follow-up, 37 (15.1%) patients had developed full-blown psychosis. In bivariate analyses, current non-psychotic bipolar disorder associated significantly with TTP. In multivariate analyses, current bipolar disorder, somatoform and unipolar depressive disorders associated positively, and anxiety disorders negatively, with TTP. Conclusions Both life-time and current mood and anxiety disorders are highly prevalent among clinical help-seeking CHR patients and need to be carefully evaluated. Among CHR patients, occurrence of bipolar, somatoform and depressive disorders seems to predict TTP, while occurrence of anxiety disorder may predict non-transition to psychosis.
doi_str_mv 10.1016/j.schres.2012.03.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1031159496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0920996412001612</els_id><sourcerecordid>1031159496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-d9ce168117845ad2c1ae2937a6505432894363c0f9a6019922c825764a6ffbe63</originalsourceid><addsrcrecordid>eNqFks9u1DAQxi0EokvhDRDyBYlLgv_FiTkgVVWBSpVaqXC2XMfpOs3GwZMU9ol4TWa12yIhJE724TffzHzfEPKas5Izrt_3Jfh1DlAKxkXJZMlY84SseFXLQlTMPCUrZgQrjNHqiLwA6BljvGL1c3IkhNLKCLEiv05-RqDntI3udkwQgLqxpXN2I8Q5ppHOiU6w9esEyMWR-iGO0buBruPtusgR7ujk5hjGGejZ1eU1nXLqg58_0KucYMJfvA-0S8OQfhTLRFNHhar-JZOW-VEJG3VpydSnZZxzDPCSPOvcAOHV4T0m3z6dfT39Ulxcfj4_PbkovFL1XLTGB64bzutGVa4VnrsgjKydrlilpGiMklp61hmnGTdogW9EVWvldNfdBC2Pybu9Lq7xfQkw200EH4bBjSEtYDmTnFdGmR2q9qjHRSGHzk45blzeImR3Edne7iOyu4gskxYjwrI3hw7LzSa0j0UPmSDw9gA4QIc6zMJH-MPh4NpohtzHPRfQj_sYMnZD93xoY0bbbZvi_yb5W-AhlbuwDdBjACN6bbkFrLHXu3PaXRMXeEiaC_kb5xbHjw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1031159496</pqid></control><display><type>article</type><title>Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Salokangas, Raimo K.R ; Ruhrmann, Stephan ; von Reventlow, Heinrich Graf ; Heinimaa, Markus ; Svirskis, Tanja ; From, Tiina ; Luutonen, Sinikka ; Juckel, Georg ; Linszen, Don ; Dingemans, Peter ; Birchwood, Max ; Patterson, Paul ; Schultze-Lutter, Frauke ; Klosterkötter, Joachim</creator><creatorcontrib>Salokangas, Raimo K.R ; Ruhrmann, Stephan ; von Reventlow, Heinrich Graf ; Heinimaa, Markus ; Svirskis, Tanja ; From, Tiina ; Luutonen, Sinikka ; Juckel, Georg ; Linszen, Don ; Dingemans, Peter ; Birchwood, Max ; Patterson, Paul ; Schultze-Lutter, Frauke ; Klosterkötter, Joachim ; the EPOS group ; EPOS group</creatorcontrib><description>Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim was to examine distributions of life-time and current Axis I diagnoses, and their association with TTP in CHR patients. Methods In the EPOS (European Prediction of Psychosis Study) project, six European outpatient centres in four countries examined 245 young help-seeking patients, who fulfilled the inclusion criteria for clinical risk of psychosis according to the Structured Interview for Prodromal Syndromes (SIPS 3.0) or the Bonn Scale for the Assessment of Basic Symptoms — Prediction List basic symptoms (BASBS-P). Patients who had experienced a psychotic episode lasting more than one week were excluded. Baseline and life-time diagnoses were assessed by the Structured Clinical Interview for DSM-IV (SCID-I). TTP was defined by continuation of BLIPS for more than seven days and predicted in Cox-regression analysis. Results Altogether, 71% of the CHR patients had one or more life-time and 62% one or more current SCID-I diagnosis; about a half in each category received a diagnosis of life-time depressive and anxiety disorder. Currently, 34% suffered from depressive and 39% from anxiety disorder. Four percent received a current SCID diagnosis of bipolar, and 6.5% of somatoform disorder. During follow-up, 37 (15.1%) patients had developed full-blown psychosis. In bivariate analyses, current non-psychotic bipolar disorder associated significantly with TTP. In multivariate analyses, current bipolar disorder, somatoform and unipolar depressive disorders associated positively, and anxiety disorders negatively, with TTP. Conclusions Both life-time and current mood and anxiety disorders are highly prevalent among clinical help-seeking CHR patients and need to be carefully evaluated. Among CHR patients, occurrence of bipolar, somatoform and depressive disorders seems to predict TTP, while occurrence of anxiety disorder may predict non-transition to psychosis.</description><identifier>ISSN: 0920-9964</identifier><identifier>EISSN: 1573-2509</identifier><identifier>DOI: 10.1016/j.schres.2012.03.008</identifier><identifier>PMID: 22464922</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Adult and adolescent clinical studies ; Anxiety Disorders - epidemiology ; Axis I diagnoses ; Biological and medical sciences ; Bipolar Disorder - epidemiology ; Clinical high-risk patients ; Comorbidity ; Depressive Disorder - epidemiology ; Europe - epidemiology ; Female ; Follow-Up Studies ; Humans ; Male ; Medical sciences ; Other psychotic disorders ; Prospective Studies ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Psychotic Disorders - epidemiology ; Risk Factors ; Somatoform Disorders - epidemiology ; Transition to psychosis</subject><ispartof>Schizophrenia research, 2012-07, Vol.138 (2), p.192-197</ispartof><rights>Elsevier B.V.</rights><rights>2012 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-d9ce168117845ad2c1ae2937a6505432894363c0f9a6019922c825764a6ffbe63</citedby><cites>FETCH-LOGICAL-c447t-d9ce168117845ad2c1ae2937a6505432894363c0f9a6019922c825764a6ffbe63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0920996412001612$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26016960$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22464922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salokangas, Raimo K.R</creatorcontrib><creatorcontrib>Ruhrmann, Stephan</creatorcontrib><creatorcontrib>von Reventlow, Heinrich Graf</creatorcontrib><creatorcontrib>Heinimaa, Markus</creatorcontrib><creatorcontrib>Svirskis, Tanja</creatorcontrib><creatorcontrib>From, Tiina</creatorcontrib><creatorcontrib>Luutonen, Sinikka</creatorcontrib><creatorcontrib>Juckel, Georg</creatorcontrib><creatorcontrib>Linszen, Don</creatorcontrib><creatorcontrib>Dingemans, Peter</creatorcontrib><creatorcontrib>Birchwood, Max</creatorcontrib><creatorcontrib>Patterson, Paul</creatorcontrib><creatorcontrib>Schultze-Lutter, Frauke</creatorcontrib><creatorcontrib>Klosterkötter, Joachim</creatorcontrib><creatorcontrib>the EPOS group</creatorcontrib><creatorcontrib>EPOS group</creatorcontrib><title>Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries</title><title>Schizophrenia research</title><addtitle>Schizophr Res</addtitle><description>Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim was to examine distributions of life-time and current Axis I diagnoses, and their association with TTP in CHR patients. Methods In the EPOS (European Prediction of Psychosis Study) project, six European outpatient centres in four countries examined 245 young help-seeking patients, who fulfilled the inclusion criteria for clinical risk of psychosis according to the Structured Interview for Prodromal Syndromes (SIPS 3.0) or the Bonn Scale for the Assessment of Basic Symptoms — Prediction List basic symptoms (BASBS-P). Patients who had experienced a psychotic episode lasting more than one week were excluded. Baseline and life-time diagnoses were assessed by the Structured Clinical Interview for DSM-IV (SCID-I). TTP was defined by continuation of BLIPS for more than seven days and predicted in Cox-regression analysis. Results Altogether, 71% of the CHR patients had one or more life-time and 62% one or more current SCID-I diagnosis; about a half in each category received a diagnosis of life-time depressive and anxiety disorder. Currently, 34% suffered from depressive and 39% from anxiety disorder. Four percent received a current SCID diagnosis of bipolar, and 6.5% of somatoform disorder. During follow-up, 37 (15.1%) patients had developed full-blown psychosis. In bivariate analyses, current non-psychotic bipolar disorder associated significantly with TTP. In multivariate analyses, current bipolar disorder, somatoform and unipolar depressive disorders associated positively, and anxiety disorders negatively, with TTP. Conclusions Both life-time and current mood and anxiety disorders are highly prevalent among clinical help-seeking CHR patients and need to be carefully evaluated. Among CHR patients, occurrence of bipolar, somatoform and depressive disorders seems to predict TTP, while occurrence of anxiety disorder may predict non-transition to psychosis.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Anxiety Disorders - epidemiology</subject><subject>Axis I diagnoses</subject><subject>Biological and medical sciences</subject><subject>Bipolar Disorder - epidemiology</subject><subject>Clinical high-risk patients</subject><subject>Comorbidity</subject><subject>Depressive Disorder - epidemiology</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Other psychotic disorders</subject><subject>Prospective Studies</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Psychotic Disorders - epidemiology</subject><subject>Risk Factors</subject><subject>Somatoform Disorders - epidemiology</subject><subject>Transition to psychosis</subject><issn>0920-9964</issn><issn>1573-2509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks9u1DAQxi0EokvhDRDyBYlLgv_FiTkgVVWBSpVaqXC2XMfpOs3GwZMU9ol4TWa12yIhJE724TffzHzfEPKas5Izrt_3Jfh1DlAKxkXJZMlY84SseFXLQlTMPCUrZgQrjNHqiLwA6BljvGL1c3IkhNLKCLEiv05-RqDntI3udkwQgLqxpXN2I8Q5ppHOiU6w9esEyMWR-iGO0buBruPtusgR7ujk5hjGGejZ1eU1nXLqg58_0KucYMJfvA-0S8OQfhTLRFNHhar-JZOW-VEJG3VpydSnZZxzDPCSPOvcAOHV4T0m3z6dfT39Ulxcfj4_PbkovFL1XLTGB64bzutGVa4VnrsgjKydrlilpGiMklp61hmnGTdogW9EVWvldNfdBC2Pybu9Lq7xfQkw200EH4bBjSEtYDmTnFdGmR2q9qjHRSGHzk45blzeImR3Edne7iOyu4gskxYjwrI3hw7LzSa0j0UPmSDw9gA4QIc6zMJH-MPh4NpohtzHPRfQj_sYMnZD93xoY0bbbZvi_yb5W-AhlbuwDdBjACN6bbkFrLHXu3PaXRMXeEiaC_kb5xbHjw</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Salokangas, Raimo K.R</creator><creator>Ruhrmann, Stephan</creator><creator>von Reventlow, Heinrich Graf</creator><creator>Heinimaa, Markus</creator><creator>Svirskis, Tanja</creator><creator>From, Tiina</creator><creator>Luutonen, Sinikka</creator><creator>Juckel, Georg</creator><creator>Linszen, Don</creator><creator>Dingemans, Peter</creator><creator>Birchwood, Max</creator><creator>Patterson, Paul</creator><creator>Schultze-Lutter, Frauke</creator><creator>Klosterkötter, Joachim</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120701</creationdate><title>Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries</title><author>Salokangas, Raimo K.R ; Ruhrmann, Stephan ; von Reventlow, Heinrich Graf ; Heinimaa, Markus ; Svirskis, Tanja ; From, Tiina ; Luutonen, Sinikka ; Juckel, Georg ; Linszen, Don ; Dingemans, Peter ; Birchwood, Max ; Patterson, Paul ; Schultze-Lutter, Frauke ; Klosterkötter, Joachim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-d9ce168117845ad2c1ae2937a6505432894363c0f9a6019922c825764a6ffbe63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Anxiety Disorders - epidemiology</topic><topic>Axis I diagnoses</topic><topic>Biological and medical sciences</topic><topic>Bipolar Disorder - epidemiology</topic><topic>Clinical high-risk patients</topic><topic>Comorbidity</topic><topic>Depressive Disorder - epidemiology</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Other psychotic disorders</topic><topic>Prospective Studies</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Psychotic Disorders - epidemiology</topic><topic>Risk Factors</topic><topic>Somatoform Disorders - epidemiology</topic><topic>Transition to psychosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salokangas, Raimo K.R</creatorcontrib><creatorcontrib>Ruhrmann, Stephan</creatorcontrib><creatorcontrib>von Reventlow, Heinrich Graf</creatorcontrib><creatorcontrib>Heinimaa, Markus</creatorcontrib><creatorcontrib>Svirskis, Tanja</creatorcontrib><creatorcontrib>From, Tiina</creatorcontrib><creatorcontrib>Luutonen, Sinikka</creatorcontrib><creatorcontrib>Juckel, Georg</creatorcontrib><creatorcontrib>Linszen, Don</creatorcontrib><creatorcontrib>Dingemans, Peter</creatorcontrib><creatorcontrib>Birchwood, Max</creatorcontrib><creatorcontrib>Patterson, Paul</creatorcontrib><creatorcontrib>Schultze-Lutter, Frauke</creatorcontrib><creatorcontrib>Klosterkötter, Joachim</creatorcontrib><creatorcontrib>the EPOS group</creatorcontrib><creatorcontrib>EPOS group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Schizophrenia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salokangas, Raimo K.R</au><au>Ruhrmann, Stephan</au><au>von Reventlow, Heinrich Graf</au><au>Heinimaa, Markus</au><au>Svirskis, Tanja</au><au>From, Tiina</au><au>Luutonen, Sinikka</au><au>Juckel, Georg</au><au>Linszen, Don</au><au>Dingemans, Peter</au><au>Birchwood, Max</au><au>Patterson, Paul</au><au>Schultze-Lutter, Frauke</au><au>Klosterkötter, Joachim</au><aucorp>the EPOS group</aucorp><aucorp>EPOS group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries</atitle><jtitle>Schizophrenia research</jtitle><addtitle>Schizophr Res</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>138</volume><issue>2</issue><spage>192</spage><epage>197</epage><pages>192-197</pages><issn>0920-9964</issn><eissn>1573-2509</eissn><abstract>Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim was to examine distributions of life-time and current Axis I diagnoses, and their association with TTP in CHR patients. Methods In the EPOS (European Prediction of Psychosis Study) project, six European outpatient centres in four countries examined 245 young help-seeking patients, who fulfilled the inclusion criteria for clinical risk of psychosis according to the Structured Interview for Prodromal Syndromes (SIPS 3.0) or the Bonn Scale for the Assessment of Basic Symptoms — Prediction List basic symptoms (BASBS-P). Patients who had experienced a psychotic episode lasting more than one week were excluded. Baseline and life-time diagnoses were assessed by the Structured Clinical Interview for DSM-IV (SCID-I). TTP was defined by continuation of BLIPS for more than seven days and predicted in Cox-regression analysis. Results Altogether, 71% of the CHR patients had one or more life-time and 62% one or more current SCID-I diagnosis; about a half in each category received a diagnosis of life-time depressive and anxiety disorder. Currently, 34% suffered from depressive and 39% from anxiety disorder. Four percent received a current SCID diagnosis of bipolar, and 6.5% of somatoform disorder. During follow-up, 37 (15.1%) patients had developed full-blown psychosis. In bivariate analyses, current non-psychotic bipolar disorder associated significantly with TTP. In multivariate analyses, current bipolar disorder, somatoform and unipolar depressive disorders associated positively, and anxiety disorders negatively, with TTP. Conclusions Both life-time and current mood and anxiety disorders are highly prevalent among clinical help-seeking CHR patients and need to be carefully evaluated. Among CHR patients, occurrence of bipolar, somatoform and depressive disorders seems to predict TTP, while occurrence of anxiety disorder may predict non-transition to psychosis.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>22464922</pmid><doi>10.1016/j.schres.2012.03.008</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0920-9964
ispartof Schizophrenia research, 2012-07, Vol.138 (2), p.192-197
issn 0920-9964
1573-2509
language eng
recordid cdi_proquest_miscellaneous_1031159496
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Adult
Adult and adolescent clinical studies
Anxiety Disorders - epidemiology
Axis I diagnoses
Biological and medical sciences
Bipolar Disorder - epidemiology
Clinical high-risk patients
Comorbidity
Depressive Disorder - epidemiology
Europe - epidemiology
Female
Follow-Up Studies
Humans
Male
Medical sciences
Other psychotic disorders
Prospective Studies
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Psychotic Disorders - epidemiology
Risk Factors
Somatoform Disorders - epidemiology
Transition to psychosis
title Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A51%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Axis%20I%20diagnoses%20and%20transition%20to%20psychosis%20in%20clinical%20high-risk%20patients%20EPOS%20project:%20Prospective%20follow-up%20of%20245%20clinical%20high-risk%20outpatients%20in%20four%20countries&rft.jtitle=Schizophrenia%20research&rft.au=Salokangas,%20Raimo%20K.R&rft.aucorp=the%20EPOS%20group&rft.date=2012-07-01&rft.volume=138&rft.issue=2&rft.spage=192&rft.epage=197&rft.pages=192-197&rft.issn=0920-9964&rft.eissn=1573-2509&rft_id=info:doi/10.1016/j.schres.2012.03.008&rft_dat=%3Cproquest_cross%3E1031159496%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1031159496&rft_id=info:pmid/22464922&rft_els_id=S0920996412001612&rfr_iscdi=true